van der Plas Ellen, Nelson Eric, Becknell Brian, Dawson Anne E, Wilson Camille S, Dawson Jeffrey D, Alge Joseph L, Harshman Lyndsay A
Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock.
Division of Hematology and Oncology, Arkansas Children's Hospital Research Institute, Little Rock.
JAMA Netw Open. 2025 Feb 3;8(2):e2457601. doi: 10.1001/jamanetworkopen.2024.57601.
Pediatric patients with chronic kidney disease (CKD) exhibit reduced cerebellum volume, which is associated with neurocognitive deficits and a lower estimated glomerular filtration rate (eGFR), even before dialysis or transplantation. These differences have not been examined within the context of age-related brain changes during childhood to early adulthood.
To evaluate differences in age-related neurodevelopmental changes in patients with CKD compared with control participants and to investigate associations between regional neuroanatomy, functional outcomes, and disease-related variables.
DESIGN, SETTING, AND PARTICIPANTS: Case-control study of individuals aged 6 through 21 years with and without CKD at an academic medical center in Iowa City, Iowa, from September 2016 to August 2024.
Neurocognitive testing; 3-T magnetic resonance imaging.
Participants completed standardized neurocognitive assessments and quantitative neuroanatomical scans. Brain regions of interest (ROIs) were analyzed for volumetric differences using automated pipelines. Multivariable linear models assessed neurocognitive and neuroanatomical differences between groups, including an age × group interaction for ROI analyses.
The sample included 124 individuals (mean [SD] age, 12.8 [4.5] years; 74 [59.7%] male), including 87 control participants (44 [50.6%] male) and 37 participants with CKD (30 [81.1%] male). The mean (SD) eGFR was 71.3 [25.5] mL/min/1.73 m2 for the CKD group. Participants with CKD scored lower than control participants on most neurocognitive measures included in the analyses. The CKD group showed differential age-related changes in cerebellar gray matter (β = -0.10; 95% CI, -0.18 to -0.01; Cohen f = 0.22) and white matter (β = -0.09; 95% CI, -0.19 to -0.00; Cohen f = 0.19). The age × group interaction approached but did not reach significance for amygdala volume (β = 0.09; 95% CI, -0.01 to 0.19; Cohen f = 0.18; P = .06). Volumetric variation in these regions was associated with proxy ratings of executive function in patients with CKD. A significant, positive association between cerebellar gray matter and eGFR was observed in the CKD group (β = 0.04; 95% CI, 0.00 to 0.02; P = .01).
In this case-control study, age-related neurodevelopmental differences were observed in pediatric patients with CKD compared with healthy peers. Reductions in cerebellar volume were associated with cognitive deficits and lower kidney function. These findings underscore the importance of monitoring neurodevelopmental trajectories in children with CKD, as early interventions may be necessary to mitigate cognitive impairments associated with CKD.
患有慢性肾脏病(CKD)的儿科患者小脑体积减小,这与神经认知缺陷以及较低的估计肾小球滤过率(eGFR)相关,甚至在透析或移植之前就是如此。这些差异尚未在儿童期至成年早期与年龄相关的大脑变化背景下进行研究。
评估与对照参与者相比,CKD患者在与年龄相关的神经发育变化方面的差异,并研究区域神经解剖结构、功能结局和疾病相关变量之间的关联。
设计、设置和参与者:2016年9月至2024年8月在爱荷华州爱荷华市的一家学术医疗中心对6至21岁患有和未患有CKD的个体进行的病例对照研究。
神经认知测试;3-T磁共振成像。
参与者完成了标准化的神经认知评估和定量神经解剖扫描。使用自动化流程分析感兴趣的脑区(ROI)的体积差异。多变量线性模型评估了组间的神经认知和神经解剖差异,包括用于ROI分析的年龄×组交互作用。
样本包括124名个体(平均[标准差]年龄,12.8[4.5]岁;74[59.7%]为男性),其中包括87名对照参与者(44[50.6%]为男性)和37名CKD参与者(30[81.1%]为男性)。CKD组的平均(标准差)eGFR为71.3[25.5]mL/min/1.73 m²。在分析中纳入的大多数神经认知指标上,CKD参与者的得分低于对照参与者。CKD组在小脑灰质(β = -0.10;95%置信区间,-0.18至-0.01;科恩f = 0.22)和白质(β = -0.09;95%置信区间,-0.19至-0.00;科恩f = 0.19)中显示出与年龄相关的差异。年龄×组交互作用接近但未达到杏仁核体积的显著性(β = 0.09;95%置信区间,-0.01至0.19;科恩f = 0.18;P = 0.06)。这些区域的体积变化与CKD患者执行功能的代理评分相关。在CKD组中观察到小脑灰质与eGFR之间存在显著的正相关(β = 0.04;95%置信区间,0.00至0.02;P = 0.01)。
在这项病例对照研究中,与健康同龄人相比,患有CKD的儿科患者存在与年龄相关的神经发育差异。小脑体积减小与认知缺陷和肾功能降低相关。这些发现强调了监测CKD儿童神经发育轨迹的重要性,因为可能需要早期干预来减轻与CKD相关的认知障碍。